These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 23600473
1. Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. de Pace RC, Liu X, Sun M, Nie S, Zhang J, Cai Q, Gao W, Pan X, Fan Z, Wang S. J Liposome Res; 2013 Sep; 23(3):187-96. PubMed ID: 23600473 [Abstract] [Full Text] [Related]
2. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. Cancer Lett; 2007 Jan 08; 245(1-2):232-41. PubMed ID: 16519995 [Abstract] [Full Text] [Related]
3. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Rocha S, Generalov R, Pereira Mdo C, Peres I, Juzenas P, Coelho MA. Nanomedicine (Lond); 2011 Jan 08; 6(1):79-87. PubMed ID: 21182420 [Abstract] [Full Text] [Related]
4. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Stuart EC, Scandlyn MJ, Rosengren RJ. Life Sci; 2006 Nov 17; 79(25):2329-36. PubMed ID: 16945390 [Abstract] [Full Text] [Related]
5. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Landis-Piwowar KR, Huo C, Chen D, Milacic V, Shi G, Chan TH, Dou QP. Cancer Res; 2007 May 01; 67(9):4303-10. PubMed ID: 17483343 [Abstract] [Full Text] [Related]
7. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo. Ding J, Yao J, Xue J, Li R, Bao B, Jiang L, Zhu JJ, He Z. ACS Appl Mater Interfaces; 2015 Aug 19; 7(32):18145-55. PubMed ID: 26225796 [Abstract] [Full Text] [Related]
8. Novel D-ring analog of epigallocatechin-3-gallate inhibits tumor growth and VEGF expression in breast carcinoma cells. Waleh NS, Chao WR, Bensari A, Zaveri NT. Anticancer Res; 2005 Aug 19; 25(1A):397-402. PubMed ID: 15816564 [Abstract] [Full Text] [Related]
9. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK. Int J Oncol; 2004 Mar 19; 24(3):703-10. PubMed ID: 14767556 [Abstract] [Full Text] [Related]
10. Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25. Zan L, Chen Q, Zhang L, Li X. Bioengineered; 2019 Dec 19; 10(1):374-382. PubMed ID: 31431131 [Abstract] [Full Text] [Related]
11. The anti-cancer effects of (-)-epigallocatechin-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells. Hsu YC, Liou YM. J Cell Physiol; 2011 Oct 19; 226(10):2721-30. PubMed ID: 21792929 [Abstract] [Full Text] [Related]
12. Chemopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced gastrointestinal cancer in rat model. Xu Q, Yang CH, Liu Q, Jin XF, Xu XT, Tong JL, Xiao SD, Ran ZH. J Dig Dis; 2011 Jun 19; 12(3):181-7. PubMed ID: 21615871 [Abstract] [Full Text] [Related]
13. Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2'-deoxycytidine in human breast cancer cells. Tyagi T, Treas JN, Mahalingaiah PK, Singh KP. Breast Cancer Res Treat; 2015 Feb 19; 149(3):655-68. PubMed ID: 25663548 [Abstract] [Full Text] [Related]
14. Effects of green tea, matcha tea and their components epigallocatechin gallate and quercetin on MCF‑7 and MDA-MB-231 breast carcinoma cells. Schröder L, Marahrens P, Koch JG, Heidegger H, Vilsmeier T, Phan-Brehm T, Hofmann S, Mahner S, Jeschke U, Richter DU. Oncol Rep; 2019 Jan 19; 41(1):387-396. PubMed ID: 30320348 [Abstract] [Full Text] [Related]
15. Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Du GJ, Zhang Z, Wen XD, Yu C, Calway T, Yuan CS, Wang CZ. Nutrients; 2012 Nov 08; 4(11):1679-91. PubMed ID: 23201840 [Abstract] [Full Text] [Related]
16. [Effects of cell growth and apoptosis of preneoplastic Syrian hamster embryo cells by green tea constituent epigallocatechin-3-gallate]. Jiao ZQ, Lü XZ, Guo YC, Kan B, Xu Y. Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Sep 08; 41(5):380-6. PubMed ID: 18206010 [Abstract] [Full Text] [Related]
17. Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice. Paul B, Hayes CS, Kim A, Athar M, Gilmour SK. Carcinogenesis; 2005 Jan 08; 26(1):119-24. PubMed ID: 15375010 [Abstract] [Full Text] [Related]
18. Cytotoxicity of epigallocatechin-3-gallate to LNCaP cells in the presence of Cu2+. Yu HN, Shen SR, Xiong YK. J Zhejiang Univ Sci B; 2005 Feb 08; 6(2):125-31. PubMed ID: 15633248 [Abstract] [Full Text] [Related]
19. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Lee SC, Chan WK, Lee TW, Lam WH, Wang X, Chan TH, Wong YC. Nutr Cancer; 2008 Feb 08; 60(4):483-91. PubMed ID: 18584482 [Abstract] [Full Text] [Related]
20. Anti-proliferative effects of green tea polyphenol EGCG on Ha-Ras-induced transformation of intestinal epithelial cells. Peng G, Wargovich MJ, Dixon DA. Cancer Lett; 2006 Jul 18; 238(2):260-70. PubMed ID: 16157446 [Abstract] [Full Text] [Related] Page: [Next] [New Search]